Michael J. Holston net worth and biography

Michael Holston Biography and Net Worth

EVP of Merck & Co., Inc.

Mike Holston is Senior Vice President, General Counsel and Secretary, of GE. In this role, Mike leads the company’s global legal, compliance and ethics, corporate secretary and environment health & safety organizations.

Mike joined GE from Merck & Co., Inc. where he most recently served as Executive Vice President and General Counsel. Before joining Merck, Mike served as Executive Vice President, General Counsel and Board Secretary of Hewlett-Packard Company.

Earlier in his career, Mike served as a prosecutor in the criminal division of the U.S. Attorney's Office for the Eastern District of Pennsylvania; he also was a partner at Morgan Lewis and was a managing partner at Drinker Biddle & Reath.

What is Michael J. Holston's net worth?: The estimated net worth of Michael J. Holston is at least $4.97 million as of February 14th, 2024. Mr. Holston owns 56,283 shares of Merck & Co., Inc. stock worth more than $4,972,941 as of March 26th. This net worth estimate does not reflect any other assets that Mr. Holston may own. Learn More about Michael J. Holston's net worth.
How do I contact Michael J. Holston?: The corporate mailing address for Mr. Holston and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at investor_relations@merck.com. Learn More on Michael J. Holston's contact information.
Has Michael J. Holston been buying or selling shares of Merck & Co., Inc.?: Michael J. Holston has not been actively trading shares of Merck & Co., Inc. during the last quarter. Learn More on Michael J. Holston's trading history.
Who are Merck & Co., Inc.'s active insiders?: Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), and Wendell Weeks (Director). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?: During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 1 times. They sold a total of 2,361 shares worth more than $209,562.36. The most recent insider tranaction occured on February, 6th when Director Inge G Thulin bought 2,833 shares worth more than $250,012.25. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..
Information on this page was last updated on 2/6/2025.

Michael J. Holston Insider Trading History at Merck & Co., Inc.

Michael J. Holston Buying and Selling Activity at Merck & Co., Inc.

Merck & Co., Inc. Company Overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Today's Range

Now: $88.06

$87.31

$89.32

50 Day Range

MA: $92.35

$83.01

$100.72

2 Week Range

Now: $88.06

$81.04

$134.63

Volume

13,807,591 shs

Average Volume

10,313,465 shs

Market Capitalization

$222.44 billion

P/E Ratio

13.08

Dividend Yield

3.42%

Beta

0.35